RecruitingNCT05044273

Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent

Evaluation of Effectiveness and Safety of Synergy™ XD Stent and Synergy Megatron™ Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study

Sponsor

Jung-min Ahn

Enrollment

2,000 participants

Start Date

Sep 1, 2022

Study Type

OBSERVATIONAL

Conditions

Cardiovascular Diseases Coronary Disease Myocardial Ischemia Heart Diseases Coronary Artery Disease

Summary

The objective of this study is to evaluate the effectiveness and safety of Synergy XD stent and Synergy Megatron™ Stent in the "real world" daily practice as compared with the other drug-eluting stents.

Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Synergy XD stent or Synergy Megatron™ Stent for people with cardiovascular diseases, coronary artery disease, and other related conditions. The study is currently recruiting participants at 23 locations. People eligible for this study include aged 19 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESynergy XD stent or Synergy Megatron™ Stent

Percutaneous coronary intervention with Synergy XD stent or Synergy Megatron™ Stent

Locations(23)

Hallym University Medical Center

Anyang, South Korea

Dong-A University Hospital

Busan, South Korea

Inje University Busan Paik Hospital

Busan, South Korea

Inje university Pusan Paik hospital

Busan, South Korea

Pusan National University Hospital

Busan, South Korea

Pusan National University Hospital

Busan, South Korea

Pusan National University Yangsan Hospital

Busan, South Korea

Gyeongsang National University Changwon Hospital

Changwon, South Korea

Samsung Changwon Hospital

Changwon, South Korea

Keimyung University Dongsan Medical Center

Daegu, South Korea

Veterans Hospital

Daegu, South Korea

Yeungnam University Medical Center

Daegu, South Korea

Gangneung Asan Hospital

Gangneung, South Korea

Chonnam National University Hospital

Gwangju, South Korea

Wonkwang University Hospital

Iksan, South Korea

CHA Bundang Medical Center, CHA University

Seongnam, South Korea

Seoul university Bundang hospital

Seongnam, South Korea

Asan Medical Center

Seoul, South Korea

Hanyang University Seoul Hospital

Seoul, South Korea

Korea University Anam Hospital

Seoul, South Korea

Korea University Guro Hospital

Seoul, South Korea

The Catholic University of Korea, ST. Vincent's Hospital

Suwon, South Korea

Ulsan University Hospital

Ulsan, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05044273

Related Trials

Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging

NCT076130991 location

Real-life Registry in Patients With Coronary Artery Disease Treated With the SELUTION Sirolimus-eluting Balloon. Selution Iberia Registry

NCT0725624911 locations

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

NCT0677963023 locations

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

NCT072582902 locations

Virtue® SAB in the Treatment of Coronary ISR Trial

NCT0704519415 locations